Founded in 2024, we have been privileged to support a growing technology-driven clients, including:
- Consumer and professional audio solutions
- Bioartificial pancreas and cell-therapy platforms
- Biotechnology for sustainable soil and material binding
- Medical imaging and vascular diagnostic systems
- Investigative analytics and security intelligence software
- Electromedical and therapeutic devices
- Intraocular lenses and ophthalmic technologies
- University-based R&D and technology transfer
- Korean academic research commercialization
- Laser and energy-based medical devices
- Aesthetic medical device technologies
- Diamond and gemstone analysis systems
- Leading clinical research and medical innovation hub
- 3D printing hardware and materials
Our Focus
At Leo, we primarily represent small and medium-sized enterprises (SMEs) as well as larger companies that actively enforce and manage dynamic patent portfolios.
By partnering with organizations that maintain ongoing R&D, we are able to engage deeply with their technologies, business, and long-term objectives. This close collaboration enables us to operate as an extension of the in-house team providing practical IP strategies aligned with commercial goals.
Our practice is built to support clients requiring complex, multi-jurisdictional strategies. We work with companies that benefit from sustained engagement and from our detailed understanding of their innovation landscape.
